Breaking news this morning about the single-dose J&J vaccine, via the New York Times: WASHINGTON — Federal health agencies on Tuesday called for an immediate pause in use of Johnson & Johnson’s single-dose coronavirus vaccine after six recipients in the United States developed a rare disorder involving blood clots within about two weeks of vaccination. All six recipients were women between the ages of 18 and 48.